Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9747 | 1124 | 46.1 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
360 | 3 | RETINA//OPHTHALMOLOGY//PHOTORECEPTOR | 34628 |
266 | 2 | RETINITIS PIGMENTOSA//OPHTHALMOLOGY//RETINA | 19390 |
9747 | 1 | LEBER CONGENITAL AMAUROSIS//RPE65//LEBERS CONGENITAL AMAUROSIS | 1124 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LEBER CONGENITAL AMAUROSIS | authKW | 954089 | 6% | 56% | 63 |
2 | RPE65 | authKW | 700008 | 5% | 49% | 53 |
3 | LEBERS CONGENITAL AMAUROSIS | authKW | 362188 | 2% | 67% | 20 |
4 | EIE EYE | address | 329184 | 9% | 12% | 103 |
5 | SUBRETINAL INJECTION | authKW | 253532 | 1% | 67% | 14 |
6 | MCGILL OCULAR GENET | address | 233508 | 2% | 36% | 24 |
7 | FM KIRBY MOL OPHTHALMOL | address | 190653 | 3% | 19% | 37 |
8 | OCULAR GENE THERAPY | authKW | 166385 | 1% | 88% | 7 |
9 | RETINAL GENE THERAPY | authKW | 158047 | 1% | 73% | 8 |
10 | AIPL1 | authKW | 124176 | 1% | 57% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Ophthalmology | 32494 | 46% | 0% | 513 |
2 | Medicine, Research & Experimental | 7625 | 31% | 0% | 349 |
3 | Genetics & Heredity | 7280 | 34% | 0% | 380 |
4 | Biotechnology & Applied Microbiology | 2798 | 22% | 0% | 247 |
5 | Biochemistry & Molecular Biology | 546 | 22% | 0% | 246 |
6 | Biology | 31 | 2% | 0% | 25 |
7 | Neurosciences | 10 | 5% | 0% | 52 |
8 | Pediatrics | 7 | 2% | 0% | 22 |
9 | Cell Biology | 6 | 3% | 0% | 39 |
10 | Cell & Tissue Engineering | 4 | 0% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EIE EYE | 329184 | 9% | 12% | 103 |
2 | MCGILL OCULAR GENET | 233508 | 2% | 36% | 24 |
3 | FM KIRBY MOL OPHTHALMOL | 190653 | 3% | 19% | 37 |
4 | STELLAR CHANCE S 310 | 84887 | 0% | 63% | 5 |
5 | MOL OPHTHALMOL | 83704 | 1% | 21% | 15 |
6 | ADV RETINAL OPHTHALM THER EUT | 81495 | 0% | 100% | 3 |
7 | OPHTHALMOL | 75032 | 48% | 1% | 537 |
8 | ADV RETINAL OCULAR THER EUT | 72438 | 0% | 67% | 4 |
9 | RECH THER EUT 1 | 62088 | 0% | 57% | 4 |
10 | UNIT GENE THER Y STEM CELL BIOL | 59939 | 1% | 28% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENE THERAPY | 28375 | 6% | 2% | 64 |
2 | HUMAN GENE THERAPY | 25496 | 5% | 2% | 56 |
3 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 20544 | 11% | 1% | 121 |
4 | MOLECULAR VISION | 19795 | 4% | 1% | 49 |
5 | MOLECULAR THERAPY | 19108 | 4% | 1% | 50 |
6 | HUMAN GENE THERAPY CLINICAL DEVELOPMENT | 16420 | 1% | 9% | 7 |
7 | OPHTHALMIC GENETICS | 8891 | 1% | 2% | 14 |
8 | JOURNAL OF GENE MEDICINE | 8491 | 2% | 1% | 21 |
9 | CURRENT GENE THERAPY | 4938 | 1% | 2% | 10 |
10 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 3879 | 4% | 0% | 49 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LEBER CONGENITAL AMAUROSIS | 954089 | 6% | 56% | 63 | Search LEBER+CONGENITAL+AMAUROSIS | Search LEBER+CONGENITAL+AMAUROSIS |
2 | RPE65 | 700008 | 5% | 49% | 53 | Search RPE65 | Search RPE65 |
3 | LEBERS CONGENITAL AMAUROSIS | 362188 | 2% | 67% | 20 | Search LEBERS+CONGENITAL+AMAUROSIS | Search LEBERS+CONGENITAL+AMAUROSIS |
4 | SUBRETINAL INJECTION | 253532 | 1% | 67% | 14 | Search SUBRETINAL+INJECTION | Search SUBRETINAL+INJECTION |
5 | OCULAR GENE THERAPY | 166385 | 1% | 88% | 7 | Search OCULAR+GENE+THERAPY | Search OCULAR+GENE+THERAPY |
6 | RETINAL GENE THERAPY | 158047 | 1% | 73% | 8 | Search RETINAL+GENE+THERAPY | Search RETINAL+GENE+THERAPY |
7 | AIPL1 | 124176 | 1% | 57% | 8 | Search AIPL1 | Search AIPL1 |
8 | LEBER CONGENITAL AMAUROSIS LCA | 122240 | 1% | 75% | 6 | Search LEBER+CONGENITAL+AMAUROSIS+LCA | Search LEBER+CONGENITAL+AMAUROSIS+LCA |
9 | LCA1 | 113186 | 0% | 83% | 5 | Search LCA1 | Search LCA1 |
10 | GUCY2D | 95071 | 1% | 50% | 7 | Search GUCY2D | Search GUCY2D |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TRAPANI, I , PUPPO, A , AURICCHIO, A , (2014) VECTOR PLATFORMS FOR GENE THERAPY OF INHERITED RETINOPATHIES.PROGRESS IN RETINAL AND EYE RESEARCH. VOL. 43. ISSUE . P. 108 -128 | 171 | 57% | 22 |
2 | COLELLA, P , AURICCHIO, A , (2012) GENE THERAPY OF INHERITED RETINOPATHIES: A LONG AND SUCCESSFUL ROAD FROM VIRAL VECTORS TO PATIENTS.HUMAN GENE THERAPY. VOL. 23. ISSUE 8. P. 796-807 | 105 | 68% | 20 |
3 | HUFNAGEL, RB , AHMED, ZM , CORREA, ZM , SISK, RA , (2012) GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS: ADVANCES AND FUTURE DIRECTIONS.GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. VOL. 250. ISSUE 8. P. 1117-1128 | 58 | 89% | 23 |
4 | TRAPANI, I , BANFI, S , SIMONELLI, F , SURACE, EM , AURICCHIO, A , (2015) GENE THERAPY OF INHERITED RETINAL DEGENERATIONS: PROSPECTS AND CHALLENGES.HUMAN GENE THERAPY. VOL. 26. ISSUE 4. P. 193 -200 | 66 | 69% | 6 |
5 | CIDECIYAN, AV , (2010) LEBER CONGENITAL AMAUROSIS DUE TO RPE65 MUTATIONS AND ITS TREATMENT WITH GENE THERAPY.PROGRESS IN RETINAL AND EYE RESEARCH. VOL. 29. ISSUE 5. P. 398-427 | 92 | 50% | 81 |
6 | CIDECIYAN, AV , JACOBSON, SG , BELTRAN, WA , SUMAROKA, A , SWIDER, M , IWABE, S , ROMAN, AJ , OLIVARES, MB , SCHWARTZ, SB , KOMAROMY, AM , ET AL (2013) HUMAN RETINAL GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS SHOWS ADVANCING RETINAL DEGENERATION DESPITE ENDURING VISUAL IMPROVEMENT.PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. VOL. 110. ISSUE 6. P. E517-E525 | 47 | 69% | 116 |
7 | BOYE, SE , BOYE, SL , LEWIN, AS , HAUSWIRTH, WW , (2013) A COMPREHENSIVE REVIEW OF RETINAL GENE THERAPY.MOLECULAR THERAPY. VOL. 21. ISSUE 3. P. 509 -519 | 81 | 43% | 75 |
8 | CARVALHO, LS , VANDENBERGHE, LH , (2015) PROMISING AND DELIVERING GENE THERAPIES FOR VISION LOSS.VISION RESEARCH. VOL. 111. ISSUE . P. 124 -133 | 64 | 65% | 7 |
9 | SMITH, AJ , BAINBRIDGE, JWB , ALI, RR , (2012) GENE SUPPLEMENTATION THERAPY FOR RECESSIVE FORMS OF INHERITED RETINAL DYSTROPHIES.GENE THERAPY. VOL. 19. ISSUE 2. P. 154 -161 | 66 | 66% | 26 |
10 | PETIT, L , KHANNA, H , PUNZO, C , (2016) ADVANCES IN GENE THERAPY FOR DISEASES OF THE EYE.HUMAN GENE THERAPY. VOL. 27. ISSUE 8. P. 563 -579 | 84 | 46% | 2 |
Classes with closest relation at Level 1 |